Cabazitaxel Accord 20 mg/mL concentrate for solution for infusion: Risk of medication errors and mix-up with Jevtana (60 mg/1.5 mL) concentrate and solvent for solution for infusion

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Active substance
cabazitaxel
Therapeutic area (MeSH)
Prostatic Neoplasms, Castration-Resistant
Procedure number
EMEA/H/C/005178
DHPC type
Medication error
Human ATC code
L01CD

How useful was this page?

Add your rating